Handbook of research on advancements in cancer therapeutics
"This book disseminates the recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trial, synthetic lethality, carbon beam radiation, and other exciting targeted therapies based on rigorous evidence to benefit trainees, oncologists, radiation oncologists,...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hershey PA, USA
IGI Global, Publisher of Timely Knowledge
[2021]
|
| Schriftenreihe: | A volume in the Advances in medical diagnosis, treatment, and care (AMDTC) book series
|
| Schlagworte: | |
| Online-Zugang: | DE-1050 DE-573 DE-898 DE-1049 DE-91 DE-706 DE-83 URL des Erstveröffentlichers |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047028491 | ||
| 003 | DE-604 | ||
| 005 | 20211203 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201125s2021 xx a||| o|||| 00||| eng d | ||
| 020 | |a 9781799865315 |9 978-1-7998-6531-5 | ||
| 024 | 7 | |a 10.4018/978-1-7998-6530-8 |2 doi | |
| 035 | |a (ZDB-98-IGB)978-1-7998-6531-5 | ||
| 035 | |a (OCoLC)1224486182 | ||
| 035 | |a (DE-599)BVBBV047028491 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1050 |a DE-706 |a DE-91 |a DE-898 |a DE-1049 |a DE-573 |a DE-83 | ||
| 245 | 1 | 0 | |a Handbook of research on advancements in cancer therapeutics |c Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), Saurabh Verma (National Institute of Pathology, India) |
| 246 | 1 | 3 | |a Advancements in cancer therapeutics |
| 264 | 1 | |a Hershey PA, USA |b IGI Global, Publisher of Timely Knowledge |c [2021] | |
| 264 | 4 | |c © 2021 | |
| 300 | |a 1 Online-Ressource (xxxvi, 913 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a A volume in the Advances in medical diagnosis, treatment, and care (AMDTC) book series |x 2475-6636 | |
| 505 | 8 | |a Chapter 1. Cancer immunotherapy: beyond checkpoint inhibitors -- Chapter 2. Therapeutic approaches to employ monoclonal antibody for cancer treatment -- Chapter 3. Advancements in cancer therapeutics: computational drug design methods used in cancer studies -- Chapter 4. Gene therapy and gene editing for cancer therapeutics -- Chapter 5. Gene editing and gene therapies in cancer treatment -- Chapter 6. Epigenetic regulation of breast cancer -- Chapter 7. Lipids, peptides, and polymers as targeted drug delivery vectors in cancer therapy -- Chapter 8. Use of lipids, polymers, and peptides for drug delivery and targeting to cancer cells or specific organs -- Chapter 9. Apoptotic pathway: a propitious therapeutic target for cancer treatment -- Chapter 10. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways -- | |
| 505 | 8 | |a Chapter 11. Receptor-based combinatorial nanomedicines: a new hope for cancer management -- Chapter 12. Targeted drug delivery in cancer treatment -- Chapter 13. Advancements in cancer therapeutics: targeted drug delivery in cancer treatment -- Chapter 14. Surfactant-based anhydrous nano carrier system for poorly aqueous soluble anti-cancer drugs -- Chapter 15. Precision medicine in cancer -- Chapter 16. Role of stem cells in cancer therapeutics -- Chapter 17. Cancer stem cells and advanced novel technologies in oncotherapy -- Chapter 18. Recent research and development in stem cell therapy for cancer treatment: promising future and challenges -- Chapter 19. Utilization of bio-imaging in cancer studies -- Chapter 20. Chemopreventive and therapeutic potential of phytopharmaceuticals against oral cancer: evidence-based reports from preclinical studies in animal models -- Chapter 21. Nutrition and cancer -- | |
| 505 | 8 | |a Chapter 22. Functional mechanisms of green tea polyphenols and their molecular targets in prevention of multiple cancers -- Chapter 23. Natural product compounds for breast cancer treatment -- Chapter 24. Cancer: clinical trial design and principles -- Chapter 25. Phytopharmaceuticals in cancer treatment -- Chapter 26. Obstructions in nanoparticles conveyance, nano-drug retention, and EPR effect in cancer therapies -- Chapter 27. Monocytes as targets for cancer therapies | |
| 520 | |a "This book disseminates the recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trial, synthetic lethality, carbon beam radiation, and other exciting targeted therapies based on rigorous evidence to benefit trainees, oncologists, radiation oncologists, surgical oncologists, scientific community, and also to anyone who is merely interested in to know more about cancer biology and available therapies" - Provided by publisher | ||
| 650 | 4 | |a Cancer / Treatment | |
| 650 | 4 | |a Neoplasms / therapy | |
| 700 | 1 | |a Kumar, Sumit |4 edt | |
| 700 | 1 | |a Rizvi, Moshahid Alam |4 edt | |
| 700 | 1 | |a Verma, Saurabh |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, hardcover |z 978-1-7998-6530-8 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, hardcover |z 1-7998-6530-4 |
| 856 | 4 | 0 | |u https://doi.org/10.4018/978-1-7998-6530-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-98-IGB | ||
| 912 | |a ZDB-1-IGE | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032435821 | |
| 966 | e | |u https://doi.org/10.4018/978-1-7998-6530-8 |l DE-1050 |p ZDB-98-IGB |q FHD01_IGB_Kauf |x Verlag |3 Volltext | |
| 966 | e | |u http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8 |l DE-573 |p ZDB-1-IGE |x Verlag |3 Volltext | |
| 966 | e | |u http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8 |l DE-898 |p ZDB-1-IGE |x Verlag |3 Volltext | |
| 966 | e | |u http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8 |l DE-1049 |p ZDB-1-IGE |x Verlag |3 Volltext | |
| 966 | e | |u http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8 |l DE-91 |p ZDB-1-IGE |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.4018/978-1-7998-6530-8 |l DE-706 |p ZDB-98-IGB |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.4018/978-1-7998-6530-8 |l DE-83 |p ZDB-98-IGB |q TUB_EBS_IGB |x Verlag |3 Volltext | |
Datensatz im Suchindex
| DE-BY-TUM_katkey | 2599447 |
|---|---|
| _version_ | 1820858263816634368 |
| any_adam_object | |
| author2 | Kumar, Sumit Rizvi, Moshahid Alam Verma, Saurabh |
| author2_role | edt edt edt |
| author2_variant | s k sk m a r ma mar s v sv |
| author_facet | Kumar, Sumit Rizvi, Moshahid Alam Verma, Saurabh |
| building | Verbundindex |
| bvnumber | BV047028491 |
| collection | ZDB-98-IGB ZDB-1-IGE |
| contents | Chapter 1. Cancer immunotherapy: beyond checkpoint inhibitors -- Chapter 2. Therapeutic approaches to employ monoclonal antibody for cancer treatment -- Chapter 3. Advancements in cancer therapeutics: computational drug design methods used in cancer studies -- Chapter 4. Gene therapy and gene editing for cancer therapeutics -- Chapter 5. Gene editing and gene therapies in cancer treatment -- Chapter 6. Epigenetic regulation of breast cancer -- Chapter 7. Lipids, peptides, and polymers as targeted drug delivery vectors in cancer therapy -- Chapter 8. Use of lipids, polymers, and peptides for drug delivery and targeting to cancer cells or specific organs -- Chapter 9. Apoptotic pathway: a propitious therapeutic target for cancer treatment -- Chapter 10. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways -- Chapter 11. Receptor-based combinatorial nanomedicines: a new hope for cancer management -- Chapter 12. Targeted drug delivery in cancer treatment -- Chapter 13. Advancements in cancer therapeutics: targeted drug delivery in cancer treatment -- Chapter 14. Surfactant-based anhydrous nano carrier system for poorly aqueous soluble anti-cancer drugs -- Chapter 15. Precision medicine in cancer -- Chapter 16. Role of stem cells in cancer therapeutics -- Chapter 17. Cancer stem cells and advanced novel technologies in oncotherapy -- Chapter 18. Recent research and development in stem cell therapy for cancer treatment: promising future and challenges -- Chapter 19. Utilization of bio-imaging in cancer studies -- Chapter 20. Chemopreventive and therapeutic potential of phytopharmaceuticals against oral cancer: evidence-based reports from preclinical studies in animal models -- Chapter 21. Nutrition and cancer -- Chapter 22. Functional mechanisms of green tea polyphenols and their molecular targets in prevention of multiple cancers -- Chapter 23. Natural product compounds for breast cancer treatment -- Chapter 24. Cancer: clinical trial design and principles -- Chapter 25. Phytopharmaceuticals in cancer treatment -- Chapter 26. Obstructions in nanoparticles conveyance, nano-drug retention, and EPR effect in cancer therapies -- Chapter 27. Monocytes as targets for cancer therapies |
| ctrlnum | (ZDB-98-IGB)978-1-7998-6531-5 (OCoLC)1224486182 (DE-599)BVBBV047028491 |
| doi_str_mv | 10.4018/978-1-7998-6530-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05460nam a2200553 c 4500</leader><controlfield tag="001">BV047028491</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20211203 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201125s2021 xx a||| o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781799865315</subfield><subfield code="9">978-1-7998-6531-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4018/978-1-7998-6530-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-98-IGB)978-1-7998-6531-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1224486182</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047028491</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1050</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-83</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Handbook of research on advancements in cancer therapeutics</subfield><subfield code="c">Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), Saurabh Verma (National Institute of Pathology, India)</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Advancements in cancer therapeutics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hershey PA, USA</subfield><subfield code="b">IGI Global, Publisher of Timely Knowledge</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxxvi, 913 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">A volume in the Advances in medical diagnosis, treatment, and care (AMDTC) book series</subfield><subfield code="x">2475-6636</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 1. Cancer immunotherapy: beyond checkpoint inhibitors -- Chapter 2. Therapeutic approaches to employ monoclonal antibody for cancer treatment -- Chapter 3. Advancements in cancer therapeutics: computational drug design methods used in cancer studies -- Chapter 4. Gene therapy and gene editing for cancer therapeutics -- Chapter 5. Gene editing and gene therapies in cancer treatment -- Chapter 6. Epigenetic regulation of breast cancer -- Chapter 7. Lipids, peptides, and polymers as targeted drug delivery vectors in cancer therapy -- Chapter 8. Use of lipids, polymers, and peptides for drug delivery and targeting to cancer cells or specific organs -- Chapter 9. Apoptotic pathway: a propitious therapeutic target for cancer treatment -- Chapter 10. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 11. Receptor-based combinatorial nanomedicines: a new hope for cancer management -- Chapter 12. Targeted drug delivery in cancer treatment -- Chapter 13. Advancements in cancer therapeutics: targeted drug delivery in cancer treatment -- Chapter 14. Surfactant-based anhydrous nano carrier system for poorly aqueous soluble anti-cancer drugs -- Chapter 15. Precision medicine in cancer -- Chapter 16. Role of stem cells in cancer therapeutics -- Chapter 17. Cancer stem cells and advanced novel technologies in oncotherapy -- Chapter 18. Recent research and development in stem cell therapy for cancer treatment: promising future and challenges -- Chapter 19. Utilization of bio-imaging in cancer studies -- Chapter 20. Chemopreventive and therapeutic potential of phytopharmaceuticals against oral cancer: evidence-based reports from preclinical studies in animal models -- Chapter 21. Nutrition and cancer -- </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 22. Functional mechanisms of green tea polyphenols and their molecular targets in prevention of multiple cancers -- Chapter 23. Natural product compounds for breast cancer treatment -- Chapter 24. Cancer: clinical trial design and principles -- Chapter 25. Phytopharmaceuticals in cancer treatment -- Chapter 26. Obstructions in nanoparticles conveyance, nano-drug retention, and EPR effect in cancer therapies -- Chapter 27. Monocytes as targets for cancer therapies</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"This book disseminates the recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trial, synthetic lethality, carbon beam radiation, and other exciting targeted therapies based on rigorous evidence to benefit trainees, oncologists, radiation oncologists, surgical oncologists, scientific community, and also to anyone who is merely interested in to know more about cancer biology and available therapies" - Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Sumit</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rizvi, Moshahid Alam</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verma, Saurabh</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, hardcover</subfield><subfield code="z">978-1-7998-6530-8</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, hardcover</subfield><subfield code="z">1-7998-6530-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4018/978-1-7998-6530-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-98-IGB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-IGE</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032435821</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-1050</subfield><subfield code="p">ZDB-98-IGB</subfield><subfield code="q">FHD01_IGB_Kauf</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-573</subfield><subfield code="p">ZDB-1-IGE</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-898</subfield><subfield code="p">ZDB-1-IGE</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-1049</subfield><subfield code="p">ZDB-1-IGE</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-1-IGE</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-706</subfield><subfield code="p">ZDB-98-IGB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.4018/978-1-7998-6530-8</subfield><subfield code="l">DE-83</subfield><subfield code="p">ZDB-98-IGB</subfield><subfield code="q">TUB_EBS_IGB</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047028491 |
| illustrated | Illustrated |
| indexdate | 2024-12-24T08:34:05Z |
| institution | BVB |
| isbn | 9781799865315 |
| issn | 2475-6636 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032435821 |
| oclc_num | 1224486182 |
| open_access_boolean | |
| owner | DE-1050 DE-706 DE-91 DE-BY-TUM DE-898 DE-BY-UBR DE-1049 DE-573 DE-83 |
| owner_facet | DE-1050 DE-706 DE-91 DE-BY-TUM DE-898 DE-BY-UBR DE-1049 DE-573 DE-83 |
| physical | 1 Online-Ressource (xxxvi, 913 Seiten) Illustrationen |
| psigel | ZDB-98-IGB ZDB-1-IGE ZDB-98-IGB FHD01_IGB_Kauf ZDB-98-IGB TUB_EBS_IGB |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | IGI Global, Publisher of Timely Knowledge |
| record_format | marc |
| series2 | A volume in the Advances in medical diagnosis, treatment, and care (AMDTC) book series |
| spellingShingle | Handbook of research on advancements in cancer therapeutics Chapter 1. Cancer immunotherapy: beyond checkpoint inhibitors -- Chapter 2. Therapeutic approaches to employ monoclonal antibody for cancer treatment -- Chapter 3. Advancements in cancer therapeutics: computational drug design methods used in cancer studies -- Chapter 4. Gene therapy and gene editing for cancer therapeutics -- Chapter 5. Gene editing and gene therapies in cancer treatment -- Chapter 6. Epigenetic regulation of breast cancer -- Chapter 7. Lipids, peptides, and polymers as targeted drug delivery vectors in cancer therapy -- Chapter 8. Use of lipids, polymers, and peptides for drug delivery and targeting to cancer cells or specific organs -- Chapter 9. Apoptotic pathway: a propitious therapeutic target for cancer treatment -- Chapter 10. Strategies to suppress tumor angiogenesis and metastasis, overcome multi-drug resistance in cancer, target telomerase and apoptosis pathways -- Chapter 11. Receptor-based combinatorial nanomedicines: a new hope for cancer management -- Chapter 12. Targeted drug delivery in cancer treatment -- Chapter 13. Advancements in cancer therapeutics: targeted drug delivery in cancer treatment -- Chapter 14. Surfactant-based anhydrous nano carrier system for poorly aqueous soluble anti-cancer drugs -- Chapter 15. Precision medicine in cancer -- Chapter 16. Role of stem cells in cancer therapeutics -- Chapter 17. Cancer stem cells and advanced novel technologies in oncotherapy -- Chapter 18. Recent research and development in stem cell therapy for cancer treatment: promising future and challenges -- Chapter 19. Utilization of bio-imaging in cancer studies -- Chapter 20. Chemopreventive and therapeutic potential of phytopharmaceuticals against oral cancer: evidence-based reports from preclinical studies in animal models -- Chapter 21. Nutrition and cancer -- Chapter 22. Functional mechanisms of green tea polyphenols and their molecular targets in prevention of multiple cancers -- Chapter 23. Natural product compounds for breast cancer treatment -- Chapter 24. Cancer: clinical trial design and principles -- Chapter 25. Phytopharmaceuticals in cancer treatment -- Chapter 26. Obstructions in nanoparticles conveyance, nano-drug retention, and EPR effect in cancer therapies -- Chapter 27. Monocytes as targets for cancer therapies Cancer / Treatment Neoplasms / therapy |
| title | Handbook of research on advancements in cancer therapeutics |
| title_alt | Advancements in cancer therapeutics |
| title_auth | Handbook of research on advancements in cancer therapeutics |
| title_exact_search | Handbook of research on advancements in cancer therapeutics |
| title_full | Handbook of research on advancements in cancer therapeutics Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), Saurabh Verma (National Institute of Pathology, India) |
| title_fullStr | Handbook of research on advancements in cancer therapeutics Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), Saurabh Verma (National Institute of Pathology, India) |
| title_full_unstemmed | Handbook of research on advancements in cancer therapeutics Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India), Saurabh Verma (National Institute of Pathology, India) |
| title_short | Handbook of research on advancements in cancer therapeutics |
| title_sort | handbook of research on advancements in cancer therapeutics |
| topic | Cancer / Treatment Neoplasms / therapy |
| topic_facet | Cancer / Treatment Neoplasms / therapy |
| url | https://doi.org/10.4018/978-1-7998-6530-8 |
| work_keys_str_mv | AT kumarsumit handbookofresearchonadvancementsincancertherapeutics AT rizvimoshahidalam handbookofresearchonadvancementsincancertherapeutics AT vermasaurabh handbookofresearchonadvancementsincancertherapeutics AT kumarsumit advancementsincancertherapeutics AT rizvimoshahidalam advancementsincancertherapeutics AT vermasaurabh advancementsincancertherapeutics |